how does retatrutide Substack Series 3 of 6: – The Next Frontier in Longevity and Metabolic Health What is Retatrutide treatment: Boost

Phase 3 trials ongoing as of 2026

Although lowered, the changes observed in subjects treated with either repaglinide or metformin monotherapy were not significant for HbA1C (0.4 and 0.3% decrease, respectively), or fasting plasma glucose (9 mg/dl (0.5 mmol/l) increase and 5.4 mg/dl (0.3 mmol/l) decrease, respectively)

This observation led them to speculate that GLP-1 analogs might possess distinct neurotrophic properties and exert protective effects specifically on the nerve

One is to reduce the risk of missing a dose of oral GLP-1 or doubling up on a dose, since each pack corresponds to one dose

Lets get into your top Qs

Reference: DAnnibale DA et al